We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Vaccinex Inc | NASDAQ:VCNX | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.01 | 0.40% | 2.53 | 2.50 | 2.70 | 2.66 | 2.42 | 2.51 | 25,340 | 01:00:00 |
1. Name and Address of Reporting Person * VACCINEX, INC. | 2. Issuer Name and Ticker or Trading Symbol VACCINEX, INC. [ VCNX ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director _____ 10% Owner _____ Officer (give title below) _____ Other (specify below) |
|
3. Date of Earliest Transaction
(MM/DD/YYYY)
|
|
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person |
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned |
||||||||||
1.Title of Security (Instr. 3) |
2. Trans. Date | 2A. Deemed Execution Date, if any |
3. Trans. Code (Instr. 8) |
4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) |
5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) |
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
Code | V | Amount | (A) or (D) | Price |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) |
|||||||||||||||
1. Title of Derivate Security (Instr. 3) |
2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any |
4. Trans. Code (Instr. 8) |
5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) |
6. Date Exercisable and Expiration Date |
7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) |
8. Price of Derivative Security (Instr. 5) |
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
Option (Right to Acquire) | (1) | (1) | (1) | Common Stock | 4420 | 44200 | D | ||||||||
Option (Right to Acquire) | (1) | (1) | (1) | Common Stock | 4420 | 44200 | I | By Benbow Estates Ltd. (2) | |||||||
Option (Right to Acquire) | (3) | (3) | (3) | Common Stock | 4121 | 75000 | I | By Gee Eff Services Limited (4) | |||||||
Stock Option (Right to Buy) | $13.60 | (5) | 9/15/2027 | Common Stock | 6396 | 6396 | D | ||||||||
Stock Option (Right to Buy) | $5.26 | (5) | 3/30/2029 | Common Stock | 2501 | 2501 | D | ||||||||
Stock Option (Right to Buy) | $7.78 | 5/15/2020 | (6) | Common Stock | 7718 | 7718 | D | ||||||||
Stock Option (Right to Buy) | $7.17 | 9/30/2019 | A | 1856 | 9/30/2019 | 9/27/2019 | Common Stock | 1856 | $0.00 (7) | 1856 | D |
Remarks: Due to a clerical error, the Form 4 filings were incorrectly made on behalf of the Company. |
Reporting Owners |
|||||
Reporting Owner Name / Address |
|
||||
Director | 10% Owner | Officer | Other | ||
VACCINEX, INC. C/O VACCINEX, INC. 1895 MOUNT HOPE AVENUE ROCHESTER, NY 14620 |
X |
Signatures |
||
/s/ Scott E. Royer, Attorney-in-Fact for Jacob B. Frieberg | 10/4/2019 | |
**Signature of Reporting Person | Date |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |
* | If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
Note: | File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. |
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. |
1 Year Vaccinex Chart |
1 Month Vaccinex Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions